» Articles » PMID: 24275520

Sensitivity Testing of the Seizure Severity Questionnaire (SSQ)

Overview
Journal Epilepsy Behav
Date 2013 Nov 27
PMID 24275520
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The sensitivity of the Seizure Severity Questionnaire (SSQ) was evaluated using pooled data from open-label extensions of two clinical trials in patients with partial-onset seizures. The SSQ includes questions relating to frequency and helpfulness of warning signs as well as frequency, severity, and bothersomeness of ictal and postictal effects. Differences between mean change from baseline for each SSQ item for responders and nonresponders were described and compared between patients solely with complex partial seizures (CPSs: responders, n=166; nonresponders, n=127) and those solely with secondarily generalized partial seizures (SGPSs: responders, n=26; nonresponders, n=24) at baseline. Seizure Severity Questionnaire total score and individual SSQ items related to ictal movement, consciousness, bothersomeness of postictal effects, and frequency of postictal emotional effects showed differentiation between seizure type responders. These data provide further validation of the SSQ by demonstrating its sensitivity in describing treatment effects.

Citing Articles

Romanian Translation and Cultural Adaptation of the Seizure Severity Questionnaire.

Cioriceanu I, Constantin D, Zamfirescu B, Podasca P, Marceanu L, Rogozea L Neurol Int. 2024; 16(5):1005-1013.

PMID: 39311349 PMC: 11417800. DOI: 10.3390/neurolint16050076.


Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.

Oberdhan D, Bacci E, Hill J, Palsgrove A, Hareendran A Neuropsychiatr Dis Treat. 2022; 18:611-631.

PMID: 35345602 PMC: 8957350. DOI: 10.2147/NDT.S354031.


Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model.

Borghs S, Tomaszewski E, Halling K, de la Loge C Patient. 2016; 9(5):419-31.

PMID: 27002318 DOI: 10.1007/s40271-016-0165-0.